HTR2A and fatty liver disease: These results are supported by the effects of 5-HT secretion as seen in CDAA- and HFD-fed mice (Amir et al., 2020; Hurr et al., 2019; Houghton et al., 2019; Nishio et al., 2017; Mizuno and Ueno, 2017; Sabath et al., 2015; Oben et al., 2004; Borovikova et al., 2000) and on HTR2A (Choi et al., 2020) in hepatic steatosis.